Last reviewed · How we verify

NCT04723654

Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients

Recruiting now Last updated 27 November 2024
What this trial tests

trial testing Wireless Wearable Vital Sign Monitor in Prematurity in 500 participants. Currently enrolling.

Timeline
15 March 2018
Primary endpoint
31 December 2025
30 June 2026

Quick facts

Lead sponsorAnn & Robert H Lurie Children's Hospital of Chicago
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment500
Start date15 March 2018
Primary completion31 December 2025
Estimated completion30 June 2026
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Who can join

Under 18, any sex, with Prematurity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to develop biocompatible wireless electronic devices that will allow continuous, non-invasive hemodynamic and physiology measurements in the ICU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prematurity

Currently open trials in the same condition.

Other Ann & Robert H Lurie Children's Hospital of Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04723654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing